285 related articles for article (PubMed ID: 20398809)
41. Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.
Hasserjian RP; Ott G; Elenitoba-Johnson KS; Balague-Ponz O; de Jong D; de Leval L
J Hematop; 2009 Jul; 2(2):89-95. PubMed ID: 19669187
[TBL] [Abstract][Full Text] [Related]
42. MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
[TBL] [Abstract][Full Text] [Related]
43. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
44. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
Salaverria I; Siebert R
J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
[TBL] [Abstract][Full Text] [Related]
45. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
Tohda S
Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
[TBL] [Abstract][Full Text] [Related]
46. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.
Ott G
Br J Haematol; 2017 Sep; 178(6):871-887. PubMed ID: 28748558
[TBL] [Abstract][Full Text] [Related]
47. The clinicopathologic spectrum of mature aggressive B cell lymphomas.
Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Facchetti F; Pileri S; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):453-466. PubMed ID: 28844114
[TBL] [Abstract][Full Text] [Related]
48. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
49. Classifying B-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates.
Ali AE; Morgen EK; Geddie WR; Boerner SL; Massey C; Bailey DJ; da Cunha Santos G
Cancer Cytopathol; 2010 Jun; 118(3):166-72. PubMed ID: 20544708
[TBL] [Abstract][Full Text] [Related]
50. [Overview of 2008 WHO Classification of Malignant Lymphoma].
Nakamura S
Rinsho Byori; 2010 Nov; 58(11):1105-11. PubMed ID: 21229709
[TBL] [Abstract][Full Text] [Related]
51. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
Ott MM; Horn H; Rosenwald A; Ott G
Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
[TBL] [Abstract][Full Text] [Related]
53. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
[TBL] [Abstract][Full Text] [Related]
54. Double-hit B-cell lymphomas.
Aukema SM; Siebert R; Schuuring E; van Imhoff GW; Kluin-Nelemans HC; Boerma EJ; Kluin PM
Blood; 2011 Feb; 117(8):2319-31. PubMed ID: 21119107
[TBL] [Abstract][Full Text] [Related]
55. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
[TBL] [Abstract][Full Text] [Related]
56. High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification.
Ok CY; Medeiros LJ
Pathology; 2020 Jan; 52(1):68-77. PubMed ID: 31735344
[TBL] [Abstract][Full Text] [Related]
57. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP; Fedoriw Y; Weiss LM
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
[TBL] [Abstract][Full Text] [Related]
58. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
59. Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.
Das DK
J Cytol; 2018; 35(3):163-169. PubMed ID: 30089946
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India.
Selvi SK; Kar R; Basu D; Jacob SE; Dubashi B
Indian J Hematol Blood Transfus; 2016 Jun; 32(2):168-75. PubMed ID: 27065578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
